Literature DB >> 1286132

Degradation of dacarbazine in aqueous solution.

B V Shetty1, R L Schowen, M Slavik, C M Riley.   

Abstract

The effects of initial concentration (0.05-5.0 mg ml-1, 2.5 x 10(-4)-0.025 M) (pH 1-13), buffer concentration (0.01-0.075 M), light, antioxidants and co-solvents on the degradation of dacarbazine in aqueous solution were investigated at 37 degrees C. Liquid chromatography was used to monitor the degradation of dacarbazine as well as the appearance of degradation products. The kinetics of hydrolysis of dacarbazine in the dark were pseudo first-order and independent of the initial concentration of the drug. The degradation of dacarbazine was accelerated by light and at low concentration proceeded by pseudo zero-order kinetics. The pH-rate profiles showed that both the photolytic and the hydrolytic reactions were dependent on the ionization state of the molecule. The main degradation product of both hydrolysis and photolysis was detected by liquid chromatography and confirmed by mass spectrometry to be 2-azahypoxanthine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1286132     DOI: 10.1016/0731-7085(92)80096-6

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  The simulation of UV spectroscopy and electronic analysis of temozolomide and dacarbazine chemical decomposition to their metabolites.

Authors:  M Hossein Khalilian; Saber Mirzaei; Avat Arman Taherpour
Journal:  J Mol Model       Date:  2016-10-25       Impact factor: 1.810

2.  Photo- and thermal degradation of piroxicam in aqueous solution.

Authors:  M Aminuddin; U Nazim; I Ahmad
Journal:  Indian J Pharm Sci       Date:  2011-07       Impact factor: 0.975

3.  Combined Therapy with Dacarbazine and Hyperthermia Induces Cytotoxicity in A375 and MNT-1 Melanoma Cells.

Authors:  Diana Salvador; Verónica Bastos; Helena Oliveira
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

4.  Validated spectral manipulations for determination of an anti-neoplastic drug and its related impurities including its hazardous degradation product.

Authors:  Ibrahim A Naguib; Eglal A Abdelaleem; Eman S Hassan; Aml A Emam
Journal:  RSC Adv       Date:  2021-06-16       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.